APOC1 anticorps (Internal Region)

N° du produit ABIN6259989

Détail du produit anti-APOC1 anticorps

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Épitope: Internal Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp APOC1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Specificité: APOC1 Antibody detects endogenous levels of total APOC1.

Homologie: Rabbit,Dog

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human APOC1, corresponding to a region within the internal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:1000-3000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C. Stable for 12 months from date of receipt.

Date de péremption: 12 months

Détails sur APOC1

Antigène: APOC1 (Apolipoprotein C-I (APOC1))

Autre désignation: APOC1 (APOC1 Produits)

Synonymes: anticorps Apo-CIB, anticorps ApoC-IB, anticorps ALPCI, anticorps LRRG04, anticorps APOC1, anticorps apoc1, anticorps apolipoprotein C1, anticorps apolipoprotein C-I, anticorps Apolipoprotein C-I, anticorps APOC1, anticorps Apoc1, anticorps apoc1

Sujet:

Description: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.

Gene: APOC1

Poids moléculaire: 9 kDa

ID gène: 341

UniProt: P02654

Pathways: Apoptose